Sponsors

RECENT NEWS

Presymptom Health secures funding to advance rapid infection diagnostics

UK MedTech firm Presymptom Health has secured £200,000 in additional grant funding to speed-up its AI-driven infection detection technology, cutting test times to just 40-60 minutes. Presymptom Health will also use the funding to make its rapid tests compatible with a variety of widely available PCR machines, streamlining diagnostics is secondary care.

Thermo Fisher Scientific acquires Solventum’s Purification and Filtration Business

Thermo Fisher Scientific has announced that the company has entered into a definitive agreement with Solventum to acquire its Purification & Filtration business for approximately $4.1 billion in cash.

FDA authorises COVID/influenza POC multiplex molecular test

Aptitude Medical Systems has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its next-gen molecular Metrix COVID-19/Flu multiplex test.

NHS Chief to stand down at end of March

Amanda Pritchard has formally notified the NHS England Board of her decision to stand down as Chief Executive at the end of this financial year.

Spanish partnership for bioMérieux

Spanish hospital group Vall d’Hebron has entered into a new strategic research partnership with bioMérieux. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.

Alpha Laboratories celebrates 50 years

Alpha Laboratories (Eastleigh, UK) is celebrating its 50th anniversary this year, marking half a century of commitment to supporting clinicians, scientists, and patients across the globe.

Roche unveils novel sequencing by expansion technology

Roche has unveiled its proprietary, sequencing by expansion (SBX) technology, establishing a new category of next-generation sequencing. SBX chemistry, combined with an innovative sensor module, offers ultra-rapid, high-throughput sequencing that is both flexible and scalable for a broad range of applications.

New research into Ebola antibodies could lead to improved therapeutics

New research led by scientists at California’s La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.

Warnings of increased mpox transmission

International researchers have warned that the ongoing mpox outbreak in the Democratic Republic of the Congo (DRC) has the potential to spread across borders more rapidly. The mpox virus has mutated, and the new variant, clade 1b, has become more infectious.

Global Health Research Groups announced to tackle health inequality in LMICs

Twenty-five new National Institute for Health and Care Research (NIHR) Global Health Research Groups have been awarded funding under the programme’s Group 4 Call to deliver high-quality applied global health research and training in low and middle income countries (LMICs) over the next four years.

£1 million awarded to projects tackling AMR

SBRI Healthcare, an Accelerated Access Collaborative (AAC) initiative, in partnership with the Health Innovation Network, has awarded £1 million for the development of 11 innovations that improve infection prevention and control to prevent the spread of antimicrobial resistance.

Diabetes can drive the evolution of antibiotic resistance

A new study has shown that people with diabetes are more likely to develop antibiotic-resistant strains of the bacterial infection Staphylococcus aureus.

Automation advances for Leeds laboratory

A new automation track - one of the UK’s largest and most complex tracks for testing pathology samples - is being installed at the Centre for Laboratory Medicine (CfLM) at St James’s University Hospital in Leeds.

Webinar highlights UKHSA metagenomics initiative

The next webinar in the ‘UKHSA Presents’ series will look at the recently launched metagenomics Surveillance Collaboration and Analysis Programme (mSCAPE) initiative.

Yourgene Health expands prenatal screening offering

Molecular diagnostics group Yourgene Health has announced the launch in the UK of IONA Care+, a fully comprehensive non-invasive prenatal screening service for genetic conditions.

RNA technology enables novel inflammatory skin disease diagnostics

Bioimaging firm Molecular Instruments has announced a significant advancement in dermatological diagnostics through the successful development and implementation of novel laboratory-developed tests (LDTs) at the Department of Dermatology at Yale School of Medicine.

Fujifilm Irvine Scientific sells its medical media business to Astorg

Life sciences firm Fujifilm Irvine Scientific has entered into an agreement to sell its Medical Media Business Unit (MBU) to Astorg, a leading pan-European private equity firm with an extensive track record in global healthcare investments.

New insight into spread of multiple myeloma

Using single cell analysis and spatial omics, a multi-national research team has shown in detail how multiple myeloma begins to spread in the body. The recently published results could contribute to more precise diagnostics and therapy, according to the study authors.

CE mark for rheumatic diseases assay

AliveDx has announced that its MosaiQ AiPlex CTDplus multiplex assay for the diagnosis and management of systemic autoimmune rheumatic diseases (SARDs) has received the IVDR-CE mark

Biomarker test can detect Alzheimer's pathology earlier, study shows

A novel biomarker test developed at the University of Pittsburgh is able to detect Alzheimer's disease-related pathology earlier than other methods, a new study has discovered.

Latest Issues

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

Annual SHOT Symposium

Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025